283 related articles for article (PubMed ID: 32090765)
1. Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7).
Toussaint A; Hüsing P; Gumz A; Wingenfeld K; Härter M; Schramm E; Löwe B
J Affect Disord; 2020 Mar; 265():395-401. PubMed ID: 32090765
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity to change and minimal clinically important difference of Edinburgh postnatal depression scale.
Mao F; Sun Y; Wang J; Huang Y; Lu Y; Cao F
Asian J Psychiatr; 2021 Dec; 66():102873. PubMed ID: 34624746
[TBL] [Abstract][Full Text] [Related]
3. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
[TBL] [Abstract][Full Text] [Related]
4. Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder: A Randomized Clinical Trial.
Brenes GA; Danhauer SC; Lyles MF; Hogan PE; Miller ME
JAMA Psychiatry; 2015 Oct; 72(10):1012-20. PubMed ID: 26244854
[TBL] [Abstract][Full Text] [Related]
5. Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials.
Bauer-Staeb C; Kounali DZ; Welton NJ; Griffith E; Wiles NJ; Lewis G; Faraway JJ; Button KS
J Clin Epidemiol; 2021 Sep; 137():200-208. PubMed ID: 33892086
[TBL] [Abstract][Full Text] [Related]
6. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
7. Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample.
Kertz S; Bigda-Peyton J; Bjorgvinsson T
Clin Psychol Psychother; 2013; 20(5):456-64. PubMed ID: 22593009
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis.
Hughes AJ; Dunn KM; Chaffee T; Bhattarai JJ; Beier M
Arch Phys Med Rehabil; 2018 Oct; 99(10):2045-2049. PubMed ID: 29964000
[TBL] [Abstract][Full Text] [Related]
9. Comparative Responsiveness and Minimally Important Difference of Common Anxiety Measures.
Kroenke K; Baye F; Lourens SG
Med Care; 2019 Nov; 57(11):890-897. PubMed ID: 31415337
[TBL] [Abstract][Full Text] [Related]
10. Promising effects of treatment with flotation-REST (restricted environmental stimulation technique) as an intervention for generalized anxiety disorder (GAD): a randomized controlled pilot trial.
Jonsson K; Kjellgren A
BMC Complement Altern Med; 2016 Mar; 16():108. PubMed ID: 27016217
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
[TBL] [Abstract][Full Text] [Related]
12. The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.
Mossman SA; Luft MJ; Schroeder HK; Varney ST; Fleck DE; Barzman DH; Gilman R; DelBello MP; Strawn JR
Ann Clin Psychiatry; 2017 Nov; 29(4):227-234A. PubMed ID: 29069107
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of generalized anxiety disorder: older vs. young adults.
Altunoz U; Kokurcan A; Kirici S; Bastug G; Ozel-Kizil ET
Nord J Psychiatry; 2018 Feb; 72(2):97-102. PubMed ID: 29065768
[TBL] [Abstract][Full Text] [Related]
15. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal cohort study to explore the relationship between depression, anxiety and academic performance among Emirati university students.
Awadalla S; Davies EB; Glazebrook C
BMC Psychiatry; 2020 Sep; 20(1):448. PubMed ID: 32917172
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: aerobic exercise for the treatment of anxiety disorders.
Bartley CA; Hay M; Bloch MH
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():34-9. PubMed ID: 23643675
[TBL] [Abstract][Full Text] [Related]
18. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample.
Beard C; Björgvinsson T
J Anxiety Disord; 2014 Aug; 28(6):547-52. PubMed ID: 24983795
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.
Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
